Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,320 | 343 | 394 | N/A | N/A |
| Depreciation Amortization | 632 | 440 | 218 | N/A | N/A |
| Income taxes - deferred | N/A | -65 | -33 | N/A | N/A |
| Accounts receivable | 226 | 373 | -94 | N/A | N/A |
| Accounts payable and accrued liabilities | 634 | 683 | 767 | N/A | N/A |
| Other Working Capital | -4,210 | -1,007 | -386 | N/A | N/A |
| Other Operating Activity | -3,076 | -2,974 | -2,067 | 0 | 0 |
| Operating Cash Flow | $-4,474 | $-2,206 | $-1,202 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -628 | -472 | -438 | N/A | N/A |
| Investing Cash Flow | $-628 | $-472 | $-438 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -53 | -38 | -19 | N/A | N/A |
| Other Financing Activity | 4,504 | 3,861 | -5 | 0 | 0 |
| Financing Cash Flow | $4,451 | $3,823 | $-25 | $N/A | $N/A |
| Beginning Cash Position | 3,447 | 3,447 | 3,447 | N/A | N/A |
| End Cash Position | 2,797 | 4,592 | 1,783 | N/A | N/A |
| Net Cash Flow | $-650 | $1,145 | $-1,664 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,474 | -2,206 | -1,202 | N/A | N/A |
| Capital Expenditure | -628 | -472 | -438 | N/A | N/A |
| Free Cash Flow | -5,101 | -2,678 | -1,639 | 0 | 0 |